Synlait Milk

HY25 EBITDA of NZ$63.1m was described by management as "just above" the January 2025 guidance range, but the numeric range was not disclosed in the supplied excerpt, so the beat cannot be sized. No forward targets were supplied in the release extract. On shape, HY24 represented only 39.9% of FY24 revenue, indicating a traditionally second-half-weighted top line, though FY24's EBITDA pattern is too distorted by losses to read as a useful seasonal template. Annualising HY25 revenue gives NZ$1.83b, 12.0% above FY24's NZ$1.64b, but whether earnings scale proportionally into 2H is not supported by the release.

• The January 2025 EBITDA guidance range is not visible in the supplied excerpts, so the scale of the beat cannot be quantified.
• Trade payables are not disclosed, so a complete operating working capital bridge cannot be built — the OCF improvement may partly reflect payables timing.
• No segment-level commentary on margin drivers (milk price, product mix, customer wins/losses) is supplied, so it is not clear why Synlait-segment margin is so thin on strong revenue growth.
• There is no explicit FY25 earnings or leverage target, and no dividend has been declared, leaving capital allocation policy post-reset unclarified.
• Customer concentration (notably around the disclosed strategic review context) is not quantified in the supplied materials.

This briefing cannot assess the terms or likelihood of any further balance-sheet or strategic transaction, the undisclosed EBITDA guidance range, or 2H25 trading conditions.